Insider Cluster (2 insiders) ·Filed Aug 19, 2026

INSM

INSMED Inc
NEUTRAL
Impact 4/10
Horizonweeks Processed1mo ago
Insider cluster: 2 insiders, $32.6M total
Actionable Insight • Neutral

The insider sales are small relative to market cap and likely reflect routine portfolio diversification after a 49% stock surge post-earnings. Monitor for any additional insider selling at higher volumes (>0.5% of market cap) which would be more concerning. The fundamental story remains intact with rapid path to profitability and raised guidance.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+20d
INSM ▼ -8.22% at T+20d
NEUTRAL call ✗ call lost -8.22% · α vs SPY -6.70% · entry $130.66 → $119.92
Next anchor: T+60d in 6w
Latest observation: T+28 -14.75% FF3 residual α
Entry anchored
Aug 18, 04:00 PM ET
via 1-min bar
T+1d
-4.27%
call -4.27% · α -3.43%
$125.08
settled 6w ago
T+5d
-4.80%
call -4.80% · α -4.41%
$124.39
settled 5w ago
T+20d
-8.22%
call -8.22% · α -6.70%
$119.92
settled 16d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Two Insmed insiders sold a total of $32.6M in stock over the past week, including COO Roger Adsett's $31.96M sale and Director Melvin Sharoky's $638K sale. This cluster follows a blockbuster Q2 earnings beat (revenue $425.5M vs $393.4M consensus) and a raised full-year BRINSUPRI guidance to $1.25B-$1.4B. While the sales are large in absolute terms, they represent only ~0.12% of the $28.1B market cap, and the COO's sale may be a routine 10b5-1 plan transaction following a massive stock appreciation post-earnings. The cluster does not negate the strong fundamental momentum.

Key Financial Metrics

Direction
selling
Total Value
$32.6M
Insiders
2

Key Facts

  • COO Roger Adsett sold 239,800 shares for $31.96M on 2026-08-10 at $133.27
  • Director Melvin Sharoky sold 5,000 shares for $637,650 on 2026-08-17 at $127.53
  • Total insider sales of $32.6M represent ~0.12% of INSM's $28.1B market cap
  • Sales follow Q2 2026 earnings beat: revenue $425.5M vs consensus $393.4M, BRINSUPRI sales surged 49% QoQ to $309.2M
  • Full-year BRINSUPRI guidance raised to $1.25B-$1.4B from 'at least $1B'

Financial Impact

Insider sales of $32.6M total, ~0.12% of market cap — below materiality threshold

insider_sales

Risk Factors

  • COO's large sale could signal peak sentiment if it accelerates
  • Stock has appreciated significantly post-earnings, creating natural selling pressure from insiders
  • Any future insider sales cluster above 0.5% of market cap would warrant bearish reassessment

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
97% bullish (30 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INSM-1787196620318
18 reports for INSM
Performance horizon
86% Hit rate 6 of 7 directional calls best @ T+60▲ +31.86%Mar 30, 2026
Filters
Rows
Reports for INSM — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$130.66 $119.92▼ −8.22%▼ −6.70%$109.99 (−15.82%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$126.33 $129.41▲ +2.44%▲ +4.19%$109.99 (−12.93%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 8/10
$132.55 $126.68▼ −4.43%▼ −5.03%$109.99 (−17.02%)
Jul 24, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$106.92 $125.77▲ +17.63%▲ +14.00%$109.99 (+2.87%)
Jul 21, 2026
10w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$108.62 $128.46▲ +18.27%▲ +15.70%$109.99 (+1.26%)
Jul 16, 2026
11w ago
8-K
BULLISH ★ 6/10
$107.46 $126.33▲ +17.56%▲ +13.94%$109.99 (+2.35%)
Jun 26, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$104.74 $106.92▲ +2.08%▲ +2.36%$109.99 (+5.01%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$94.17 $111.54▲ +18.45%▲ +16.81%$109.99 (+16.80%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$94.17 $111.54▲ +18.45%▲ +16.81%$109.99 (+16.80%)
May 15, 2026
19w ago
S-3ASR
NEUTRAL ★ 3/10
$107.15 $95.52▼ −10.85%▼ −12.44%$109.99 (+2.65%)
Showing 10 of 18

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 20, 2026